Literature DB >> 14733829

Kidney cancer management in 2004: an update for the practicing general urologist.

John S Lam1, Oleg Shvarts, Arie S Belldegrun.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14733829     DOI： 10.1007/s11934-004-0001-2

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


× No keyword cloud information.
  11 in total

1.  Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

Authors:  R C Flanigan; S E Salmon; B A Blumenstein; S I Bearman; V Roy; P C McGrath; J R Caton; N Munshi; E D Crawford
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

2.  Nephrectomy and interleukin-2 for metastatic renal-cell carcinoma.

Authors:  A J Pantuck; A S Belldegrun; R A Figlin
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

Review 3.  The changing natural history of renal cell carcinoma.

Authors:  A J Pantuck; A Zisman; A S Belldegrun
Journal:  J Urol       Date:  2001-11       Impact factor: 7.450

4.  Renal ablative cryosurgery in selected patients with peripheral renal masses.

Authors:  R Rodriguez; D Y Chan; J T Bishoff; R B Chen; L R Kavoussi; M A Choti; F F Marshall
Journal:  Urology       Date:  2000-01       Impact factor: 2.649

5.  Laparoscopic renal cryoablation in 32 patients.

Authors:  I S Gill; A C Novick; A M Meraney; R N Chen; M G Hobart; G T Sung; J Hale; D K Schweizer; E M Remer
Journal:  Urology       Date:  2000-11-01       Impact factor: 2.649

6.  Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

Authors:  G H Mickisch; A Garin; H van Poppel; L de Prijck; R Sylvester
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

7.  Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling.

Authors:  C C Wykoff; C W Pugh; P H Maxwell; A L Harris; P J Ratcliffe
Journal:  Oncogene       Date:  2000-12-14       Impact factor: 9.867

8.  Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.

Authors:  Matthew H T Bui; David Seligson; Ken-ryu Han; Allan J Pantuck; Frederick J Dorey; Yunda Huang; Steve Horvath; Bradley C Leibovich; Shefali Chopra; Shu-Yuan Liao; Eric Stanbridge; Michael I Lerman; Aarno Palotie; Robert A Figlin; Arie S Belldegrun
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

9.  Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment.

Authors:  J Pastorek; S Pastoreková; I Callebaut; J P Mornon; V Zelník; R Opavský; M Zat'ovicová; S Liao; D Portetelle; E J Stanbridge
Journal:  Oncogene       Date:  1994-10       Impact factor: 9.867

10.  The natural history of metastatic renal cell carcinoma: a computer analysis.

Authors:  J B Dekernion; K P Ramming; R B Smith
Journal:  J Urol       Date:  1978-08       Impact factor: 7.450
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.